Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maura Dandri

Showing results (51-60 of 103) with videos related to

Pageof 11
Sort By:
Journal of Hepatology|January 9, 2014
Immune cell responses are not required to induce substantial hepatitis B virus antigen decline during pegylated interferon-alpha administrationLena Allweiss, Tassilo Volz, Marc Lütgehetmann, et al.
Journal of Hepatology|March 17, 2023
A 3-Year Course Of Bulevirtide Monotherapy May Cure Hdv Infection In CirrhoticsMaria Paola Anolli, Elisabetta Degasperi, Lena Allweiss, et al.
World Journal of Gastroenterology|January 13, 2010
Mobilization of hematopoietic progenitor cells in patients with liver cirrhosisUrsula M Gehling, Marc Willems, Kathleen Schlagner, et al.
The American Journal of Pathology|January 1, 2003
Quantitative gene expression analysis reveals transition of fetal liver progenitor cells to mature hepatocytes after transplantation in uPA/RAG-2 miceTobias Cantz, David M Zuckerman, Martin R Burda, et al.
Scientific Reports|June 18, 2017
Both interferon alpha and lambda can reduce all intrahepatic HDV infection markers in HBV/HDV infected humanized miceKatja Giersch, Maria Homs, Tassilo Volz, et al.
Journal of Hepatology|December 19, 2012
The entry inhibitor Myrcludex-B efficiently blocks intrahepatic virus spreading in humanized mice previously infected with hepatitis B virusTassilo Volz, Lena Allweiss, Mounira Ben MBarek, et al.
Gut|April 22, 2017
Proliferation of primary human hepatocytes and prevention of hepatitis B virus reinfection efficiently deplete nuclear cccDNA in vivoLena Allweiss, Tassilo Volz, Katja Giersch, et al.
Gut|January 29, 2021
Therapeutic shutdown of HBV transcripts promotes reappearance of the SMC5/6 complex and silencing of the viral genome in vivoLena Allweiss, Katja Giersch, Andrea Pirosu, et al.
The Journal of Clinical Investigation|May 1, 2019
T cell receptor grafting allows virological control of Hepatitis B virus infectionKarin Wisskirchen, Janine Kah, Antje Malo, et al.
Hepatology (Baltimore, Md.)|October 28, 2011
Humanized chimeric uPA mouse model for the study of hepatitis B and D virus interactions and preclinical drug evaluationMarc Lütgehetmann, Lida V Mancke, Tassilo Volz, et al.
Pageof 11

Showing results (51-60 of 103) with videos related to

Sort By:
Pageof 11
Journal of Hepatology|January 9, 2014
Immune cell responses are not required to induce substantial hepatitis B virus antigen decline during pegylated interferon-alpha administrationLena Allweiss, Tassilo Volz, Marc Lütgehetmann, et al.
Journal of Hepatology|March 17, 2023
A 3-Year Course Of Bulevirtide Monotherapy May Cure Hdv Infection In CirrhoticsMaria Paola Anolli, Elisabetta Degasperi, Lena Allweiss, et al.
World Journal of Gastroenterology|January 13, 2010
Mobilization of hematopoietic progenitor cells in patients with liver cirrhosisUrsula M Gehling, Marc Willems, Kathleen Schlagner, et al.
The American Journal of Pathology|January 1, 2003
Quantitative gene expression analysis reveals transition of fetal liver progenitor cells to mature hepatocytes after transplantation in uPA/RAG-2 miceTobias Cantz, David M Zuckerman, Martin R Burda, et al.
Scientific Reports|June 18, 2017
Both interferon alpha and lambda can reduce all intrahepatic HDV infection markers in HBV/HDV infected humanized miceKatja Giersch, Maria Homs, Tassilo Volz, et al.
Journal of Hepatology|December 19, 2012
The entry inhibitor Myrcludex-B efficiently blocks intrahepatic virus spreading in humanized mice previously infected with hepatitis B virusTassilo Volz, Lena Allweiss, Mounira Ben MBarek, et al.
Gut|April 22, 2017
Proliferation of primary human hepatocytes and prevention of hepatitis B virus reinfection efficiently deplete nuclear cccDNA in vivoLena Allweiss, Tassilo Volz, Katja Giersch, et al.
Gut|January 29, 2021
Therapeutic shutdown of HBV transcripts promotes reappearance of the SMC5/6 complex and silencing of the viral genome in vivoLena Allweiss, Katja Giersch, Andrea Pirosu, et al.
The Journal of Clinical Investigation|May 1, 2019
T cell receptor grafting allows virological control of Hepatitis B virus infectionKarin Wisskirchen, Janine Kah, Antje Malo, et al.
Hepatology (Baltimore, Md.)|October 28, 2011
Humanized chimeric uPA mouse model for the study of hepatitis B and D virus interactions and preclinical drug evaluationMarc Lütgehetmann, Lida V Mancke, Tassilo Volz, et al.
Pageof 11